V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007236 | 220018890 | 1.67 | 83.7 | Curative (C) | 2013-01-13 | 2013-01-18 | AML 18 TRIAL | N | Y | 220031971 | AML18 TRIAL |
| 220007237 | 220018890 | 1.75 | 0 | null | 2017-10-23 | 2017-10-23 | Dasatinib | 2 | N | 220031971 | DASATINIB |
| 220007238 | 220022012 | 1.8 | 141 | Palliative (P) | 2016-09-09 | 2016-09-13 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031979 | CISPLATIN + GEMCITABINE |
| 220007239 | 220002828 | 1.69 | null | null | 2013-10-20 | 2013-10-24 | AML16 DA 3+10 | Y | N | 220031981 | AML16 TRIAL |
| 220007240 | 220002829 | 1.75 | null | Palliative (P) | 2017-10-19 | 2017-09-22 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031982 | CARBOPLATIN + PACLITAXEL |
| 220007241 | 220002829 | 1.92 | 84 | null | 2014-11-01 | 2014-11-02 | CISPLATIN + GEMCITABINE | 02 | N | 220031982 | CISPLATIN + GEMCITABINE |
| 220007242 | 220016247 | 1.82 | 98.1 | Palliative (P) | 2018-06-11 | 2018-06-11 | Dasatinib | N | N | 220031987 | DASATINIB |
| 220007245 | 220002830 | 1.7 | 93.2 | Palliative (P) | null | 2014-04-16 | GemCarbo Days 1+8 | N | N | 220031992 | GEMCARBO |
| 220007247 | 220002832 | 1.63 | 44.9 | null | 2016-01-12 | 2016-04-26 | GemCarbo Days 1+8 | 02 | N | 220031995 | GEMCARBO |
| 220007248 | 220002833 | 1.67 | 77.2 | Curative (C) | 2014-03-30 | 2014-03-31 | AML18 PILOT TRIAL | 1 | N | 220031997 | PILOT TRIAL |
| 220007249 | 220011612 | 1.56 | 72.6 | Curative (C) | 2015-09-14 | 2015-09-14 | AML16 DA 3+10 | N | N | 220031998 | AML16 TRIAL |
| 220007250 | 220002834 | 1.61 | null | Curative (C) | 2013-10-14 | 2013-10-14 | AML18 PILOT TRIAL | N | N | 220032001 | PILOT TRIAL |
| 220007251 | 220002835 | 1.56 | 69.6 | Disease modification (D) | 2017-07-09 | 2017-07-17 | AML16 Low Dose Cytarabine | N | N | 220032004 | AML16 TRIAL |
| 220007252 | 220002835 | 1.67 | 66.5 | Curative (C) | 2017-04-23 | 2017-04-24 | IDARUBICIN + TRETINOIN | N | N | 220032004 | IDARUBICIN + TRETINOIN |
| 220007253 | 220002835 | null | 87 | Palliative (P) | 2014-12-04 | 2014-12-11 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220032004 | CARBOPLATIN + PACLITAXEL |
| 220007254 | 220002835 | 1.7 | 80 | Curative (C) | 2017-11-29 | 2017-11-29 | AML 18 TRIAL | 1 | null | 220032004 | AML18 TRIAL |
| 220007255 | 220002836 | 1.65 | 67.4 | null | null | 2014-03-27 | AML16 Azacitidine | 02 | null | 220032009 | AML16 TRIAL |
| 220007256 | 220011614 | 1.76 | 82.5 | Palliative (P) | 2016-11-26 | 2017-03-12 | GemCarbo Days 1+8 | N | null | 220032012 | GEMCARBO |
| 220007259 | 220016249 | 1.76 | 95 | null | 2014-07-05 | 2014-07-08 | Dasatinib | 02 | null | 220032022 | DASATINIB |
| 220007260 | 220002838 | 1.73 | 59.7 | Curative (C) | 2016-02-09 | 2016-02-10 | IDARUBICIN + TRETINOIN | N | N | 220032025 | IDARUBICIN + TRETINOIN |
| 220007261 | 220002839 | 1.64 | 82.95 | Curative (C) | 2017-12-17 | 2017-12-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032026 | CARBOPLATIN + PACLITAXEL |
| 220007262 | 220002840 | 1.66 | 54.8 | Curative (C) | 2014-09-07 | 2014-09-11 | AML 18 Pilot Trial | N | N | 220032027 | PILOT TRIAL |
| 220007263 | 220002840 | 1.7 | 95 | Curative (C) | 2015-02-16 | 2015-02-16 | Dasatinib | 02 | N | 220032027 | DASATINIB |
| 220007264 | 220002841 | 1.62 | 92.9 | Curative (C) | 2016-12-17 | 2016-12-17 | AML18 PILOT TRIAL | Y | N | 220032029 | PILOT TRIAL |
| 220007265 | 220002842 | 1.67 | 68.8 | Disease modification (D) | 2016-07-03 | 2016-07-03 | Dasatinib | N | N | 220032032 | DASATINIB |
| 220007266 | 220002842 | 1.83 | 83.3 | Palliative (P) | null | 2015-11-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032032 | CARBOPLATIN + PACLITAXEL |
| 220007267 | 220002843 | 1.65 | null | Disease modification (D) | 2013-02-20 | 2013-02-22 | AML16 DA 3+10 | N | N | 220032036 | AML16 TRIAL |
| 220007268 | 220002843 | null | 78.7 | Curative (C) | 2013-02-13 | 2013-02-13 | AML18 PILOT TRIAL | 1 | N | 220032036 | PILOT TRIAL |
| 220007269 | 220002844 | 1.8 | 64.7 | Curative (C) | 2015-07-13 | 2016-08-14 | AML18 PILOT TRIAL | Y | N | 220032039 | PILOT TRIAL |
| 220007270 | 220002845 | 1.75 | null | Palliative (P) | 2017-06-12 | 2017-07-24 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | Y | 220032041 | CISPLATIN + GEMCITABINE |
| 220007271 | 220011619 | 1.67 | 59.8 | Palliative (P) | 2015-08-18 | 2015-08-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220032042 | CISPLATIN + GEMCITABINE |
| 220007272 | 220002846 | 1.7 | 69.6 | Palliative (P) | 2016-08-08 | 2016-08-21 | GemCarbo Days 1+8 | N | N | 220032045 | GEMCARBO |
| 220007273 | 220002846 | 1.88 | 88.4 | Disease modification (D) | 2016-02-14 | 2016-02-14 | Dasatinib | 02 | N | 220032045 | DASATINIB |
| 220007274 | 220002846 | 1.78 | null | Curative (C) | 2014-09-02 | 2014-09-04 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220032045 | IDARUBICIN + TRETINOIN |
| 220007275 | 220002846 | 1.87 | null | null | 2017-05-14 | 2017-05-14 | AML 18 TRIAL | Y | N | 220032045 | AML18 TRIAL |
| 220007276 | 220002846 | 1.63 | 65 | Palliative (P) | 2016-01-20 | 2016-01-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032045 | CISPLATIN + GEMCITABINE |
| 220007277 | 220002847 | 1.74 | 95.6 | Curative (C) | 2014-10-12 | 2014-10-13 | AML 18 TRIAL | Y | N | 220032056 | AML18 TRIAL |
| 220007278 | 220002847 | 1.6 | 0 | Curative (C) | 2013-01-31 | 2013-01-31 | AML 18 TRIAL | 01 | N | 220032056 | AML18 TRIAL |
| 220007279 | 220002848 | 1.6 | 65 | Curative (C) | 2018-01-02 | 2018-01-02 | AML18 PILOT TRIAL | null | N | 220032061 | PILOT TRIAL |
| 220007281 | 220002849 | null | null | Disease modification (D) | 2017-06-06 | 2017-06-06 | Dasatinib | N | N | 220032064 | DASATINIB |
| 220007282 | 220002849 | 1.62 | 90 | Curative (C) | 2014-07-05 | 2014-07-05 | IDARUBICIN + TRETINOIN | null | null | 220032064 | IDARUBICIN + TRETINOIN |
| 220007283 | 220002849 | 1.65 | 78 | Curative (C) | 2014-12-18 | 2015-01-10 | Carboplatin + Paclitaxel (weekly) | 02 | N | 220032064 | CARBOPLATIN + PACLITAXEL |
| 220007284 | 220002850 | 1.57 | 47.2 | Disease modification (D) | 2016-09-25 | 2016-10-05 | AML16 DA 3+8 | N | N | 220032072 | AML16 TRIAL |
| 220007285 | 220002850 | null | 83.5 | Palliative (P) | 2014-12-11 | 2014-12-20 | GemCarbo Days 1+8 | 02 | N | 220032072 | GEMCARBO |
| 220007286 | 220002850 | 1.8 | 84.5 | Curative (C) | 2015-07-06 | 2015-07-06 | AML16 DA 3+10 | N | null | 220032072 | AML16 TRIAL |
| 220007287 | 220002850 | 1.57 | null | Curative (C) | 2015-03-27 | 2015-03-31 | AML 18 TRIAL | Y | N | 220032072 | AML18 TRIAL |
| 220007288 | 220002850 | 1.76 | 77 | Curative (C) | 2017-10-17 | 2017-10-17 | Dasatinib | N | N | 220032072 | DASATINIB |
| 220007289 | 220021278 | null | 68.3 | Neo-adjuvant (N) | 2017-02-21 | 2017-02-22 | CARBOPLATIN + PACLITAXEL | 02 | N | 220032092 | CARBOPLATIN + PACLITAXEL |
| 220007291 | 220002852 | 1.59 | 55.2 | Palliative (P) | 2015-10-26 | 2015-11-03 | GemCarbo Days 1+8 | 2 | N | 220032095 | GEMCARBO |
| 220007292 | 220002853 | null | 90 | Not known (9) | 2017-02-28 | 2017-02-28 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220032096 | IDARUBICIN + TRETINOIN |